文献速递瓣膜外科

术前三尖瓣反流对Cox-Maze IV术后结局的影响

Impact of Tricuspid Regurgitation on Outcomes After Cox-Maze IV Procedure.
PubMed 文献 · Ann Thorac Surg · 2025-10-30

本研究回顾2002至2023年407例二尖瓣手术联合Cox-Maze IV患者,按术前三尖瓣反流程度分组并行倾向评分匹配。中重度反流组术后起搏器植入、透析及30天死亡率更高,10年房性心律失常自由度更差,且同期三尖瓣手术未改善结局。

要点

  • 中重度三尖瓣反流患者Cox-Maze IV术后30天死亡率及并发症更高
  • 术前三尖瓣反流降低10年免于房性心律失常的生存率
  • 同期三尖瓣手术未显著改善这些不良结局

核心结论

  • 在二尖瓣手术联合Cox-Maze IV患者中,术前三尖瓣反流加重早期和晚期生存及复发性房性心律失常自由度。
  • 这些不良结局未因同期行三尖瓣手术而改变。

研究设计与样本

  • 按术前三尖瓣反流程度分为中重度组(TR组)和轻中度以下组(非TR组),并进行倾向评分匹配。

主要发现

  • 全部患者中108例(27%)存在中重度三尖瓣反流,其中48例(45%)接受了三尖瓣手术。
  • TR组NYHA III-IV级患者比例更高(70% vs 57%;标准化均数差0.291)。

临床怎么用

  • 对计划行二尖瓣手术联合Cox-Maze IV的患者,应充分评估术前三尖瓣反流程度以进行风险分层。
  • 中重度三尖瓣反流患者术后需加强监测起搏器植入、肾功能及房性心律失常复发风险。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients undergoing mitral valve surgery with atrial fibrillation commonly have a concomitant Cox-maze IV procedure (CMP-IV). Secondary tricuspid regurgitation (TR) is frequently present. This study evaluated the impact of preoperative TR on outcomes after the CMP-IV. METHODS: Between January 2002 and November 2023, 407 patients underwent concomitant mitral valve surgery with CMP-IV. Patients were grouped by preoperative TR severity: moderate or severe TR (TR group) and less than moderate (non-TR group). Propensity score matching was performed to balance baseline characteristics. Perioperative and late outcomes were compared in the unmatched and matched cohorts. RESULTS: Of all patients, 108 (27%) had moderate or severe TR, and 48 (45%) of them received tricuspid valve surgery. The TR group had more patients in New York Heart Association Functional Classification III and IV (70% vs 57%; standardized mean difference, 0.291). Postoperatively, TR patients had more permanent pacemaker placements (18% vs 10%; P = .036), renal failure requiring dialysis (12% vs 5%; P = .028), and 30-day mortality (7% vs 1%; P = .004). At 10 years, TR patients demonstrated worse freedom from atrial tachyarrhythmias off antiarrhythmic drugs (32% vs 63%; P = .031). After propensity score matching, 30-day mortality (9% vs 1%; P = .004) and atrial tachyarrhythmias-free survival (45% vs 24%; P = .004) at 10 years were worse in TR patients. CONCLUSIONS: In patients undergoing the concomitant CMP-IV procedure with mitral valve surgery, preoperative TR worsened both early and late survival and freedom from recurrent atrial tachyarrhythmias. These worse outcomes were not impacted by performing concomitant tricuspid valve surgery.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Yi J, Yu J, Procasky S, et al. Impact of Tricuspid Regurgitation on Outcomes After Cox-Maze IV Procedure. Ann Thorac Surg. 2025. PMID: 41173346. doi:10.1016/j.athoracsur.2025.09.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。